Stockreport

Collegium Pharmaceutical's (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations [Yahoo! Finance]

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com
PDF The company's full-year revenue guidance of $815 million at the midpoint came in 1% above analysts' estimates. Its non-GAAP profit of $2.04 per share was 4.7% below anal [Read more]